Public Profile

CoreRx, Inc.

CoreRx, Inc., a leading player in the pharmaceutical contract development and manufacturing industry, is headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotechnology firms, specialising in the development and production of complex drug formulations. With a focus on oral solid dosage forms, CoreRx offers a range of services, including formulation development, analytical testing, and commercial manufacturing. Their commitment to innovation and quality has positioned them as a preferred choice for clients seeking tailored solutions in drug development. CoreRx's notable achievements include a robust portfolio of successful product launches and a reputation for excellence in regulatory compliance, making them a key contributor to the advancement of healthcare solutions globally.

DitchCarbon Score

How does CoreRx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CoreRx, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

CoreRx, Inc.'s reported carbon emissions

CoreRx, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing carbon emissions. As the industry increasingly prioritises sustainability, CoreRx, Inc. may need to establish clear climate goals and strategies to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CoreRx, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CoreRx, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CoreRx, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Quotient Sciences Limited

GB
Research and development services (73)
Updated about 1 hour ago

Adare Pharma Solutions

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bioserv Corporation

US
Health and social work services (85)
Updated 3 days ago

Frontage Laboratories, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Catalent

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Aenova Group GmbH

DE
Real estate services (70)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers